Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Completion Update

9 Apr 2025 15:53

RNS Number : 3757E
Valereum PLC
09 April 2025
 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

09/04/2025

Valereum Plc

("Valereum", "VLRM" or the "Company")

 

DMC £19m Subscription - Expected Completion

£1m Conditional Fundraise Terminated

 

Valereum Plc (AQSE: VLRM) would like to inform the markets that the previously announced £19 million strategic deal with DMC is nearing completion and all documents have been signed and are held in escrow by the Company's legal advisers. On receipt of funds, we will update the markets accordingly.

 

The previously proposed additional £1 million subscription by a UK institutional investor will no longer proceed.

 

For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub. Here you will find all company news and additional content to further explain Valereum's strategy and products.

 

For further information, please contact:

 

Valereum Plc

Peter Sekhon, Investor Relation Director

Engage with the company directly

 

Tel: +44 7938 767319 

Investor Hub

Stanford Capital Partners

Bob Pountney/ Patrick Claridge

 

Tel: +44 023 3650 3650

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge / Gabrielle Cordeiro

 

 

Tel: +44 20 3855 5551

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information, please visit the Company's website at www.vlrm.com or to engage with the Valereum management team directly by asking questions, watching video
summaries and seeing what other shareholders have to say.

 

Navigate to our Interactive Investor
hub here: Sign Up

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXILMITMTAMBTA
Date   Source Headline
31st May 20243:02 pmRNSAgreed Subscription to Raise £2 million
31st May 202410:10 amRNSPartnership with Securities & Trading Technology
31st May 202410:10 amRNSRemuneration Update - Warrant and Option Issue
12th Apr 20247:00 amRNSAppointment of Corporate Broker
11th Apr 20249:37 amRNSResult of Annual General Meeting - April 2024
28th Mar 20242:00 pmRNSAppointment of PR Agency and Interim Funding
20th Mar 202411:05 amRNSNotice of Annual General Meeting
20th Feb 20247:00 amRNSStrategy Update and the Launch of “The Bridge”
31st Jan 20247:00 amRNSCompletion of the Acquisition of GSX Group
15th Jan 20247:00 amRNSMarket Update on Mattereum
10th Jan 20247:00 amRNSBoard Appointments, Update on EGM and AGM
22nd Dec 202312:09 pmRNSAcquisition of Valereum Collections and AGM Update
18th Dec 20237:00 amRNSAcquisition of the GSX Group
30th Nov 202310:00 amRNSNew Board Appointment
28th Nov 202310:00 amRNSRemoval of CLN’s Update
27th Nov 20237:00 amRNSRestoration to Trading & Update on Acquisition
17th Nov 20237:00 amRNSValereum PLC update on the acquisition of the GSX
27th Oct 20239:05 amRNSAppointment of New Directors
26th Oct 20238:13 amRNSChange of Directors
24th Oct 20232:21 pmRNSGSX Acquisition Update and Director Resignation
3rd Oct 20237:00 amRNSInterim Results for the six months to 30 June 2023
31st Aug 20232:22 pmRNSReverse Takeover & Suspension of Trading
31st Aug 202311:22 amRNSUpdate on the acquisition of the GSX
23rd Aug 20231:36 pmRNSAppointment of Jack Sun as Finance Director
21st Jul 202310:56 amRNSUpdate on GSX Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.